Stock MoversStock Movers

Apogee Therapeutics Soars, Synopsys Gains, Norwegian Cruise Rises on Decline in Cost of Oil

View descriptionShare

On this episode of Stock Movers:

- Apogee Therapeutics (APGE) soars after the drug developer provided maintenance data from a mid-stage trial that showed its experimental therapy deepened responses in patients with moderate-to-severe atopic dermatitis.

- Synopsys (SNPS) shares gain following reports that activist investor Elliott Investment Management has made a multibillion-dollar investment in the chip-design software company.

- Norwegian Cruise (NCLH) shares rose. Cruise companies traded higher in response to a decline in the cost of oil.

 
  • Facebook
  • X (Twitter)
  • WhatsApp
  • Email
  • Download

In 1 playlist(s)

Stock Movers

Listen for five-minute conversations on today's biggest winners and losers in the stock market.  Su 
Social links
Follow podcast
Recent clips
Browse 1,912 clip(s)